BACKGROUND: Apixaban. an oral anticoagulant for stroke and systemic embolism prevention in non-valvular atrial fibrillation (NVAF). was superior to warfarin in prevention of stroke and systemic embolism. bleeding outcomes and mortality (ARISTOTLE trial). https://www.spidertattooz.com/